Rebecca Taub

Yaklaşan katılımlar

• 10th Antifibrotic Drug Development Summit 2026

  1–3 Dec 2026Boston, United States of America

  • KonuşmacıReverse Translating Resmetirom’s Clinical Success to Inform the Next Generation of Antifibrotic Development

Geçmiş katılımlar

• 10th MASH Drug Development Summit 2026Davetli konuşmacı

  15–17 Sept 2026Boston, United States of America

  • Davetli konuşmacıAdapting Mash Development Strategies Within An Evolving Treatment Landscape To Define Clinical Value, Enable Differentiation & Establish Future Standards Of Care

Şu etkinlikteki diğer konuşmacılar: 10th Antifibrotic Drug Development Summit 2026

• Bernard Allan

  Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical

• Alexander Barron

  Principal Scientist II, Novartis AG

• Jeffrey Bornstein

  CMO, Mediar Therapeutics

• Victor Bustos

  Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals

• Steve De Vos

  Head of Translational Sciences, Fibrocor Therapeutics

• Zoltan Derdak

  Medical Director, Takeda Pharmaceutical

Etkinlik sayfasında 22 konuşmacının tümünü gör

Şu etkinlikteki diğer konuşmacılar: 10th MASH Drug Development Summit 2026

• Ornella Barrandon

  Senior Director, Cellarity

• Robert Beardsley

  Chief Executive Officer, Cirius Therapeutics

• Selma Boulenouar

  Faculty, Harvard Medical School and Mass General Brigham

• Doreen Chan

  Associate Director, Clinical Research, Akero Therapeutics

• Amy Curley

  Vice President, Discovery Biology, Sepia Therapeutics

• Kevin Hart

  Scientific Director & Associate Research Fellow, Pfizer

Etkinlik sayfasında 21 konuşmacının tümünü gör